In-home wireless devices that track disease progression in Parkinson’s patients are becoming increasingly popular. These devices have the potential to greatly improve the quality of life for patients by providing information about their progress and helping to identify early signs of decline.
There are a number of in-home wireless devices available that track disease progression in Parkinson’s patients. One such device is theWearable Activity and Biometric Sensor (WABiSe), developed by the startup company NeuroMetrix. The WABiSe is a wearable device that monitors a patient’s Parkinson’s disease progression by measuring their activity level and biometrics.
The WABiSe is worn on the wrist and uses an accelerometer to measure activity level. It also collects data on heart rate, skin conductance, and body temperature. This data is then transmitted wirelessly to a base station, where it can be monitored by the patient’s caregivers.
The WABiSe is just one of many in-home wireless devices that are becoming available to help patients with Parkinson’s disease. These devices have the potential to greatly improve the quality of life for patients by providing information about their progress and helping to identify early signs of decline.
In-home wireless device tracks disease progression in Parkinson’s patients
A new in-home wireless device has the potential to radically change the way Parkinson’s disease is monitored, by helping to track the progression of the disease in real-time.
The device, which has been developed by American start-up company NeuroTrek, is a wearable, sensor-based system that can be worn on the body. It is designed to track the symptoms of Parkinson’s disease and to provide information that can help with the management of the condition.
The NeuroTrek system includes a wearable device, a mobile app and a web-based platform. The device is worn on the body and uses sensors to track the user’s movement, tremor and other symptoms. The data collected by the device is then transmitted to the mobile app, which can be used by clinicians to track the progress of the disease.
The NeuroTrek system has been trialled with a number of patients and has shown promising results. The company is now working to commercialise the device and to make it available to patients worldwide.
The potential of the NeuroTrek system lies in its ability to provide real-time data on the progression of Parkinson’s disease. This could help to improve the management of the condition and to tailor treatments to the individual needs of patients. In the future, the device could also be used to track the symptoms of other neurological conditions.